Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott launches amplification system and chlamydia test

This article was originally published in Clinica

Executive Summary

Abbott has launched its DNA-amplification chlamydia test. The June 1st launch includes all less regulated markets, worldwide according to marketing manager Eric Zohare - which essentially means those outside France, Japan and the US. An Abbott spokesman told Clinica that shipment began on May 31st to Australia, Canada, Austria, Denmark, Finland, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, the UK and South Africa.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel